Hypermarcas Shares Outstanding 2009-2019 | HYPMY

Hypermarcas shares outstanding history from 2009 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Hypermarcas shares outstanding for the quarter ending September 30, 2019 were 0.636B, a 0.59% decline year-over-year.
  • Hypermarcas 2018 shares outstanding were 0.639B, a 1.43% increase from 2017.
  • Hypermarcas 2017 shares outstanding were 0.631B, a 0.15% decline from 2016.
  • Hypermarcas 2016 shares outstanding were 0.631B, a 1.91% decline from 2015.
Hypermarcas Annual Shares Outstanding
(Millions of Shares)
2018 639
2017 631
2016 631
2015 644
2014 629
2013
2012 671
2011 607
2010 524
2009
2008
Hypermarcas Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 636
Q2 2019 636
Q1 2019 630
Q4 2018 639
Q3 2018 640
Q2 2018 631
Q1 2018 638
Q4 2017 631
Q3 2017 633
Q2 2017 608
Q1 2017 642
Q4 2016 631
Q3 2016 632
Q2 2016 643
Q1 2016 644
Q4 2015 644
Q3 2015 628
Q2 2015 616
Q1 2015 648
Q4 2014 650
Q3 2014 632
Q2 2014 631
Q1 2014 616
Q4 2013
Q3 2013 617
Q2 2013 644
Q1 2013 626
Q4 2012 594
Q3 2012 622
Q2 2012 743
Q1 2012 510
Q4 2011
Q3 2011 635
Q2 2011
Q1 2011 165
Q4 2010 549
Q3 2010
Q2 2010 533
Q1 2010
Q4 2009
Q3 2009 223
Q2 2009 199
Q1 2009 199
Q4 2008
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.646B $0.978B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.758B 39.93
Takeda Pharmaceutical (TAK) Japan $62.374B 9.86
Astellas Pharma (ALPMY) Japan $32.724B 16.34
Eisai (ESALY) Japan $21.612B 41.66
Merck (MKGAF) Germany $16.401B 22.38
Grifols, S.A (GRFS) Spain $16.254B 21.30
Neurocrine Biosciences (NBIX) United States $9.639B 455.09
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $8.907B 36.24
Jazz Pharmaceuticals (JAZZ) Ireland $8.545B 10.91
Ionis Pharmaceuticals (IONS) United States $8.458B 17.13
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
IPSEN SA ADR (IPSEY) France $7.617B 0.00
STADA ARZNEIMI (STDAF) Germany $6.004B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.990B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Arrowhead Pharmaceuticals (ARWR) United States $5.400B 81.77
Evotec AG (EVTCY) Germany $4.191B 67.73
United Therapeutics (UTHR) United States $4.087B 0.00
Sage Therapeutics (SAGE) United States $3.959B 0.00
Nektar Therapeutics (NKTR) United States $3.955B 0.00
FibroGen (FGEN) United States $3.870B 113.72
PTC Therapeutics (PTCT) United States $3.316B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.273B 12.05
ChemoCentryx (CCXI) United States $2.534B 0.00
Zogenix (ZGNX) United States $2.433B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.150B 0.00
Xencor (XNCR) United States $2.130B 64.74
Tilray (TLRY) Canada $2.108B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.976B 63.00
Heron Therapeutics (HRTX) United States $1.941B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.829B 54.10
USANA Health Sciences (USNA) United States $1.760B 18.78
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.525B 10.41
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Corcept Therapeutics (CORT) United States $1.474B 17.92
Theravance Biopharma (TBPH) Cayman Islands $1.432B 0.00
Endo (ENDP) Ireland $1.370B 2.52
Enanta Pharmaceuticals (ENTA) United States $1.148B 26.10
Portola Pharmaceuticals (PTLA) United States $1.118B 0.00
Karyopharm Therapeutics (KPTI) United States $1.070B 0.00
Aerie Pharmaceuticals (AERI) United States $1.053B 0.00
Dermira (DERM) United States $1.044B 0.00
Akebia Therapeutics (AKBA) United States $0.955B 0.00
Radius Health (RDUS) United States $0.907B 0.00
Collegium Pharmaceutical (COLL) United States $0.785B 0.00
ImmunoGen (IMGN) United States $0.683B 0.00
Flexion Therapeutics (FLXN) United States $0.668B 0.00
TherapeuticsMD (TXMD) United States $0.626B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.576B 0.00
Molecular Templates (MTEM) United States $0.507B 0.00
Organogenesis Holdings (ORGO) United States $0.501B 0.00
DURECT (DRRX) United States $0.483B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.483B 0.00
Translate Bio (TBIO) United States $0.483B 0.00
Ardelyx (ARDX) United States $0.470B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.453B 0.00
Innate Pharma SA (IPHYF) France $0.438B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.429B 52.00
Siga Technologies (SIGA) United States $0.422B 9.63
BioSpecifics Technologies Corp (BSTC) United States $0.419B 18.08
Aptorum Group (APM) Hong Kong, SAR China $0.418B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.412B 0.00
Calithera Biosciences (CALA) United States $0.398B 0.00
Lannett Co Inc (LCI) United States $0.393B 4.58
Spectrum Pharmaceuticals (SPPI) United States $0.366B 0.00
Recro Pharma (REPH) United States $0.366B 0.00
Harpoon Therapeutics (HARP) United States $0.357B 0.00
OptiNose (OPTN) United States $0.356B 0.00
Indivior (INVVY) United States $0.335B 1.21
KalVista Pharmaceuticals (KALV) United States $0.331B 0.00
Rafael Holdings (RFL) United States $0.325B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.289B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.286B 0.00
MEI Pharma (MEIP) United States $0.256B 0.00
Concert Pharmaceuticals (CNCE) United States $0.248B 0.00
Concordia (CXRXF) Canada $0.248B 0.00
Jounce Therapeutics (JNCE) United States $0.241B 3.22
Ocular Therapeutix (OCUL) United States $0.223B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.210B 0.00
IMV INC (IMV) Canada $0.203B 0.00
Nature's Sunshine Products (NATR) United States $0.188B 32.43
Taiwan Liposome (TLC) Taiwan $0.170B 0.00
Xeris Pharmaceuticals (XERS) United States $0.167B 0.00
CannTrust Holdings (CTST) Canada $0.167B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.151B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.146B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Redhill Biopharma (RDHL) Israel $0.134B 0.00
CV Sciences (CVSI) United States $0.125B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.114B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.114B 0.00
Otonomy (OTIC) United States $0.110B 0.00
PolarityTE (PTE) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Aquestive Therapeutics (AQST) United States $0.103B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.100B 0.00
Champions Oncology (CSBR) United States $0.098B 0.00
MediWound (MDWD) Israel $0.082B 0.00
CTI BioPharma (CTIC) United States $0.080B 0.00
Neos Therapeutics (NEOS) United States $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.077B 23.18
Aclaris Therapeutics (ACRS) United States $0.076B 0.00
Infinity Pharmaceuticals (INFI) United States $0.067B 0.00
Natural Alternatives (NAII) United States $0.066B 16.52
Entasis Therapeutics Holdings (ETTX) United States $0.064B 0.00
Nivalis Therapeutics (ALPN) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
RENEURON GP (RNUGF) United Kingdom $0.061B 0.00
Onconova Therapeutics (ONTX) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.048B 0.00
Iterum Therapeutics (ITRM) Ireland $0.046B 0.00
Jaguar Animal Health (JAGX) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Biomerica (BMRA) United States $0.029B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.028B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.019B 0.00
VAXART, INC (VXRT) United States $0.018B 0.00
Shineco (TYHT) China $0.018B 0.00
Novan (NOVN) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Lipocine (LPCN) United States $0.013B 0.00
Flex Pharma (SLRX) United States $0.013B 0.00
Vical (BBI) United States $0.013B 0.00
Heat Biologics (HTBX) United States $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00